pyrazolanthrone has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, C; Nishigaki, K; Ruscetti, S; Thompson, D; Yugawa, T | 1 |
| Hong, L; Huang, Z; Li, H; Miao, B; Na, N; Zhang, J; Zhao, D | 1 |
2 other study(ies) available for pyrazolanthrone and losartan potassium
| Article | Year |
|---|---|
Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.
Topics: Animals; Anthracenes; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Transformed; Cell Proliferation; Cell Transformation, Viral; Cells, Cultured; Erythropoietin; Extracellular Signal-Regulated MAP Kinases; Flavonoids; JNK Mitogen-Activated Protein Kinases; Leukemia, Experimental; MAP Kinase Kinase Kinases; Mice; Retroviridae Infections; Signal Transduction; Spleen Focus-Forming Viruses; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Virus Infections | 2005 |
Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation.
Topics: Acetylcysteine; Animals; Anthracenes; Apoptosis; Erythropoietin; Gene Expression Regulation; Humans; Imidazoles; Interferon-gamma; Kidney; Kidney Transplantation; Lentivirus; MAP Kinase Kinase 4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Pyrimidines; Rats; Reperfusion Injury; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor | 2018 |